BDSX vs DHR · rev $52.4M vs P/E 39, rev $6.26B
Biodesix Inc (BDSX) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported BDSX revenue for 2026-06-30 was $52.4M. Net income was -$15.1M. BDSX currently screens at market cap $157.6M.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
BDSX currently screens at market cap $157.6M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the BDSX and DHR stock pages for the full models.
Not investment advice.